IVD MEDICAL (01931) spent HKD 7.7236 million to repurchase 1.187 million shares on November 28th.

22:19 28/11/2025

Huajian Medical (01931) announced that on November 28, 2025, the company spent 7.7236 million Hong Kong dollars to repurchase 1.187 million shares, with a repurchase price of 6.37-6.53 Hong Kong dollars per share.

IVD MEDICAL (01931) announced on November 28, 2025, that the company will spend 7.7236 million Hong Kong dollars to repurchase 1.187 million shares, at a repurchase price of 6.37-6.53 Hong Kong dollars per share.

ALLEGRO CULTURE (00550) has met the resumption conditions of the stock exchange. Trading will resume on December 1st.

WAN KEI GROUP (01718) announces its interim results, with a profit attributable to shareholders of HK$1.08 million, turning a loss into a profit year-on-year.

ARES ASIA (00645) releases interim results, with shareholders' net loss of USD 721,000, an increase of 10.58% year-on-year.

ALLEGRO CULTURE (00550) has met the resumption conditions of the stock exchange. Trading will resume on December 1st.

WAN KEI GROUP (01718) announces its interim results, with a profit attributable to shareholders of HK$1.08 million, turning a loss into a profit year-on-year.

ARES ASIA (00645) releases interim results, with shareholders' net loss of USD 721,000, an increase of 10.58% year-on-year.